GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (NAS:IMCC) » Definitions » Net Income Including Noncontrolling Interests

IMCC (IM Cannabis) Net Income Including Noncontrolling Interests : $-4.05 Mil (TTM As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is IM Cannabis Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

IM Cannabis's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was $0.12 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was $-4.05 Mil.

IM Cannabis Net Income Including Noncontrolling Interests Historical Data

The historical data trend for IM Cannabis's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Net Income Including Noncontrolling Interests Chart

IM Cannabis Annual Data
Trend Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.43 -14.47 -140.82 -7.62 -8.26

IM Cannabis Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.45 -2.52 -0.80 -0.85 0.12

IM Cannabis Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of IM Cannabis's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

IM Cannabis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (NAS:IMCC) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
XCNQ:MVMD TSX:AVNT TSXV:PCLO XCNQ:OILS XCNQ:SE TSXV:MPH TSXV:DHB TSXV:CANB XCNQ:CLC XCNQ:PWR ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
IMCC:Canada
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
Website
https://www.imcannabis.com
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.